Accelerate Diagnostics, Inc.
AXDXNASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$859918
P/E Ratio—
52W High$2.09
52W Low$0.01
Accelerate Diagnostics, Inc. (AXDX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AXDX · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2025Report Date: Mar 21, 2025EPS Actual
-$0.41
Revenue
$0.00B
Fiscal Period
Q1 FY2025
FY ends December
Report Date
Mar 21, 2025
After Market Close
✓ 1-Quarter EPS Beat Streak
AXDX reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2025 | Nov 5, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Aug 6, 2025 | — | — | — | — | — | — |
| — Q1 FY2025 | Mar 21, 2025 | — | -$0.41 | — | $0.00B | — | — |
| ▲ Q1 FY2025 | Mar 20, 2025 | -$0.50 | -$0.37 | +26.0% | $0.00B | $0.00B | -9.7% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -$0.47 | -$0.59 | -25.5% | $0.00B | $0.00B | -0.8% |
| ▲ Q3 FY2024 | Aug 8, 2024 | -$0.55 | -$0.53 | +3.6% | $0.00B | $0.00B | -0.8% |
| ▼ Q2 FY2024 | May 8, 2024 | -$0.72 | -$0.88 | -22.2% | $0.00B | $0.00B | -2.6% |
| ▼ Q1 FY2024 | Mar 28, 2024 | -$0.62 | -$0.81 | -30.6% | $0.00B | $0.00B | -13.0% |
Q4 FY2025
Nov 5, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 6, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 21, 2025
EPS Actual
-$0.41
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 20, 2025Beat
EPS Actual
-$0.37
EPS Est.
-$0.50
EPS Surpr.
+26.0%
Revenue
$0.00B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
-$0.59
EPS Est.
-$0.47
EPS Surpr.
-25.5%
Revenue
$0.00B
Q3 FY2024
Aug 8, 2024Beat
EPS Actual
-$0.53
EPS Est.
-$0.55
EPS Surpr.
+3.6%
Revenue
$0.00B
Q2 FY2024
May 8, 2024Miss
EPS Actual
-$0.88
EPS Est.
-$0.72
EPS Surpr.
-22.2%
Revenue
$0.00B
Q1 FY2024
Mar 28, 2024Miss
EPS Actual
-$0.81
EPS Est.
-$0.62
EPS Surpr.
-30.6%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q3 FY2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q2 FY2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q1 FY2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Q4 FY2025 | $-0.52 | $-0.52 | $-0.52 | 1 |
| Q3 FY2025 | $-0.50 | $-0.50 | $-0.50 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2025 | Mar 21, 2025 | — | $1.13 | $1.06 | -6.19% |
| ▲ Q1 FY2025 | Mar 20, 2025 | +26.0% | $1.11 | $1.13 | +1.80% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -25.5% | $1.99 | $1.97 | -1.01% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +3.6% | $1.35 | $1.42 | +5.19% |
| ▼ Q2 FY2024 | May 8, 2024 | -22.2% | $0.90 | $0.91 | +0.56% |
| ▼ Q1 FY2024 | Mar 28, 2024 | -30.6% | $1.01 | $0.99 | -1.98% |
| ▲ Q4 FY2023 | Nov 9, 2023 | +2.1% | $5.76 | $5.90 | +2.43% |
| ▼ Q3 FY2023 | Aug 10, 2023 | -57.3% | $6.75 | $6.85 | +1.48% |
Q1 FY2025-6.19%
Report Date
Mar 21, 2025
EPS Beat/Miss
—
Price Before
$1.13
Price After
$1.06
Q1 FY2025+1.80%
Report Date
Mar 20, 2025
EPS Beat/Miss
+26.0%
Price Before
$1.11
Price After
$1.13
Q4 FY2024-1.01%
Report Date
Nov 7, 2024
EPS Beat/Miss
-25.5%
Price Before
$1.99
Price After
$1.97
Q3 FY2024+5.19%
Report Date
Aug 8, 2024
EPS Beat/Miss
+3.6%
Price Before
$1.35
Price After
$1.42
Q2 FY2024+0.56%
Report Date
May 8, 2024
EPS Beat/Miss
-22.2%
Price Before
$0.90
Price After
$0.91
Q1 FY2024-1.98%
Report Date
Mar 28, 2024
EPS Beat/Miss
-30.6%
Price Before
$1.01
Price After
$0.99
Q4 FY2023+2.43%
Report Date
Nov 9, 2023
EPS Beat/Miss
+2.1%
Price Before
$5.76
Price After
$5.90
Q3 FY2023+1.48%
Report Date
Aug 10, 2023
EPS Beat/Miss
-57.3%
Price Before
$6.75
Price After
$6.85
Avg Beat Reaction+3.14%
Avg Miss Reaction-0.24%
Beat Rate3 / 8 quarters
Largest Move-6.19% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AXDX ends December
Accelerate Diagnostics, Inc. (AXDX) most recently reported earnings on March 21, 2025 for Q1 FY2025, posting EPS of $-0.41 (in line with the analyst consensus of —). The next AXDX earnings date is expected around September 1, 2026.
Each quarter, investors track AXDX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AXDX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AXDX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AXDX earnings · 4 questionsAccelerate Diagnostics, Inc.'s next earnings report is expected around September 1, 2026. AXDX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AXDX historically reports after market close (AMC).
AXDX earnings datewhen is AXDX earningsAXDX next earnings datewhen does AXDX report earningsAXDX earnings calendar
▸ Source: FMP · Accelerate Diagnostics, Inc. SEC filings · US GAAP · Accelerate Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026